Duality Biotherapeutics, Inc. (HKG:9606)

Duality Biotherapeutics Statistics

Total Valuation

HKG:9606 has a market cap or net worth of HKD 30.53 billion. The enterprise value is 29.06 billion.

Market Cap	30.53B
Enterprise Value	29.06B

Important Dates

The next estimated earnings date is Tuesday, August 26, 2025.

Earnings Date	Aug 26, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:9606 has 88.04 million shares outstanding.

Current Share Class	88.04M
Shares Outstanding	88.04M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.02%
Owned by Institutions (%)	15.43%
Float	38.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.78
PB Ratio	-14.19
P/TBV Ratio	n/a
P/FCF Ratio	101.84
P/OCF Ratio	100.39
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-25.99
EV / Sales	14.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	96.93

Financial Position

The company has a current ratio of 0.49

Current Ratio	0.49
Quick Ratio	0.48
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	0.02
Interest Coverage	-748.16

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-6.51%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	10.50%
Revenue Per Employee	12.15M
Profits Per Employee	-6.58M
Employee Count	170
Asset Turnover	1.08
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:9606 has paid 38.19 million in taxes.

Income Tax	38.19M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	304.50
200-Day Moving Average	n/a
Relative Strength Index (RSI)	55.42
Average Volume (20 Days)	194,852

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:9606 had revenue of HKD 2.07 billion and -1.12 billion in losses. Loss per share was -139.73.

Revenue	2.07B
Gross Profit	835.02M
Operating Income	-199.04M
Pretax Income	-1.08B
Net Income	-1.12B
EBITDA	-195.51M
EBIT	-199.04M
Loss Per Share	-139.73

Balance Sheet

The company has 1.49 billion in cash and 5.63 million in debt, giving a net cash position of 1.48 billion or 16.82 per share.

Cash & Cash Equivalents	1.49B
Total Debt	5.63M
Net Cash	1.48B
Net Cash Per Share	16.82
Equity (Book Value)	-2.15B
Book Value Per Share	-269.73
Working Capital	-2.09B

Cash Flow

In the last 12 months, operating cash flow was 304.12 million and capital expenditures -4.34 million, giving a free cash flow of 299.78 million.

Operating Cash Flow	304.12M
Capital Expenditures	-4.34M
Free Cash Flow	299.78M
FCF Per Share	3.41

Margins

Gross margin is 40.42%, with operating and profit margins of -9.63% and -54.11%.

Gross Margin	40.42%
Operating Margin	-9.63%
Pretax Margin	-52.26%
Profit Margin	-54.11%
EBITDA Margin	-9.46%
EBIT Margin	-9.63%
FCF Margin	14.51%

Dividends & Yields

HKG:9606 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-3.66%
FCF Yield	0.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:9606 has an Altman Z-Score of -1.94 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.94
Piotroski F-Score	2